Advertisement

Topics

PDS Biotechnology and Merck study head and neck cancer combo therapy

15:40 EDT 8 Aug 2017 | Elsevier Business Intelligence

PDS Biotechnology Corp. is pairing its immunotherapy PDS0101 with Merck & Co. Inc.’s checkpoint inhibitor Keytruda (pembrol...

Original Article: PDS Biotechnology and Merck study head and neck cancer combo therapy

NEXT ARTICLE

More From BioPortfolio on "PDS Biotechnology and Merck study head and neck cancer combo therapy"

Quick Search
Advertisement
 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...